Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07291544Completed

Management of Supraventricular Tachycardias in Children

Role: lead

NCT07091214Not Yet Recruiting

Molecular Transcriptomics in Diagnosing Pediatric Kidney Transplant Rejection: the PANDA-Kids-ATLAS Study

Role: collaborator

NCT05349162Completed

Epicardial vs. Transvenous ICDs in Children

Role: lead

NCT04842851Completed

Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle

Role: lead

NCT04205461Unknown

Prospective Evaluation of Programmed Ventricular Stimulation Before Pulmonary Valve Replacement in Patients With Tetralogy of Fallot

Role: lead

NCT04202796Unknown

Catheter Ablation in Congenital Heart Disease: French National Prospective Registry

Role: lead

NCT02520960Completed

Unipolar Atrial Electrogram Modification Combined to the Contact Force Sensing Technology for Pulmonary Vein Isolation

Role: collaborator

All 7 trials loaded